Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Nov 15;94(6):795-805.
doi: 10.1002/ccd.28175. Epub 2019 Mar 22.

Impact of baseline cigarette smoking status on clinical outcome after transcatheter aortic valve replacement

Masieh Abawi  1 , Lennart van Gils  2 , Pierfrancesco Agostoni  1   3 , Nicolas M van Mieghem  2 , Nynke H M Kooistra  1 , Charlotte S van Dongen  1 , Romy C van Jaarsveld  1 , Peter P T de Jaegere  2 , Pieter A F M Doevendans  1   4 , Pieter R Stella  1
Affiliations
Comparative Study

Impact of baseline cigarette smoking status on clinical outcome after transcatheter aortic valve replacement

Masieh Abawi et al. Catheter Cardiovasc Interv. .

Abstract

Objectives: To explore the prevalence of smoking, and its association with clinical and mortality outcome among patients undergoing transcatheter aortic valve replacement (TAVR).

Background: Less data exist regarding the effect of baseline smoking status on clinical and mortality outcome among patients undergoing TAVR.

Methods: Consecutive patients who underwent TAVR at two high volume Dutch centers were included. Smoking status was prospectively questioned by a structured interview at admission. Primary endpoint was 1-year all-cause mortality after TAVR.

Results: A total of 913 consecutive patients (80.1 ± 7.6 years; logistic EuroSCORE: 16.5 ± 9.9%) who underwent TAVR for severe aortic valve stenosis were included. There were 47% (n = 432) males, and 57% (n = 522) never-smokers, and 35% (n = 317) prior-smokers, and 8% (n = 74) current-smokers. Smokers (i.e., prior-smokers or current-smokers) were younger compared to never-smokers (78.9 ± 7.9 and 76.4 ± 8.0 vs. 81.3 ± 7.1, P < 0.000, respectively). Median follow-up time was 365 (interquartile range [IQR]: 280-365) days. Overall, prior-smoking was not associated with all-cause mortality at 1-year following TAVR (hazard ratio [HR] 0.83, 95% confidence interval [CI] 0.55-1.23). After stratification according to sex, male prior-smokers showed better 1-year survival after TAVR than male never-smokers (12% vs. 20%; P = 0.018, respectively, HR 0.52, 95% CI 0.29-0.89), while this reversed effect was not observed among female prior-smokers versus female never-smokers after TAVR (HR 1.70, 95% CI 0.95-3.05).

Conclusions: Overall, baseline prior-smokers had similar 1-year mortality outcome after TAVR compared with baseline never-smokers. However, there was a reversed association between baseline prior-smoking status and 1-year mortality after TAVR among males, which could partially be explained due to the favorable baseline characteristics.

Keywords: TAVR; mortality; paradox; smoking.

PubMed Disclaimer

References

REFERENCES

    1. The Economics of Tobacco and Tobacco Control. Monograph 21. National Cancer Institute and the World Health Organization; 2016 Available from: https://cancercontrol.cancer.gov/brp/tcrb/monographs/21/.
    1. GBDRF Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1345-1422.
    1. U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Printed with corrections, January 2014.
    1. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004;328(7455):1519.
    1. Pirie K, Peto R, Reeves GK, Green J, Beral V, Million Women Study C. The 21st century hazards of smoking and benefits of stopping: A prospective study of one million women in the UK. Lancet. 2013;381(9861):133-141.

MeSH terms

LinkOut - more resources